New Delhi, 13 November (H.S.): The government has stepped up monitoring of prices of 137 anti-cancer drugs to provide relief to cancer patients. The National Pharmaceutical Pricing Authority (NPPA) has directed all State Drug Controllers to ensure that pharmaceutical companies, medical stores and hospitals strictly comply with the revised prices.

The revised prices of these medicines came into effect on November 9. Pharmaceutical companies, retailers and hospitals are now required to sell the medicines at the prescribed prices. They must also prominently display updated price lists at their business premises and on their websites.

The NPPA has made it clear that action will be initiated against any retailer or company found charging more than the prescribed prices. The initiative aims to ensure that cancer patients have access to medicines at fair and more affordable rates.

Patients can report complaints regarding overcharging, shortages or the non-availability of medicines through the Pharma Sahi Daam app or portal. Complaints can also be lodged through the NPPA helpline at 1800-111-255 and its official website. The Authority has directed all State Drug Controllers to submit reports on the action taken by November 16, 2026.

---------------

Hindusthan Samachar / Jun Sarkar